A5020682913- Renal cell carcinoma treatment
- Renal and Vascular Pathologies
- Organ Donation and Transplantation
- Renal and related cancers
- Pediatric Urology and Nephrology Studies
- Bladder and Urothelial Cancer Treatments
- Neurological Complications and Syndromes
- Genetic and Kidney Cyst Diseases
- Urinary and Genital Oncology Studies
- Estrogen and related hormone effects
- Menopause: Health Impacts and Treatments
- Renal Transplantation Outcomes and Treatments
- Urologic and reproductive health conditions
- Prostate Cancer Treatment and Research
- Kidney Stones and Urolithiasis Treatments
- Prostate Cancer Diagnosis and Treatment
- Medical Imaging and Pathology Studies
- Phytoestrogen effects and research
- Minimally Invasive Surgical Techniques
- Ureteral procedures and complications
- Organ Transplantation Techniques and Outcomes
- Anorectal Disease Treatments and Outcomes
- Pituitary Gland Disorders and Treatments
- Adrenal Hormones and Disorders
- Urological Disorders and Treatments
Clinique Pasteur
2020-2021
Hôpital Rangueil
2013-2020
Centre Hospitalier Universitaire de Rennes
2019
Université de Toulouse
2015-2019
Centre Hospitalier Universitaire de Toulouse
2014-2018
Université Toulouse III - Paul Sabatier
2015-2017
Inserm
2015-2017
Institut des Maladies Métaboliques et Cardiovasculaires
2017
Centre Hospitalier Universitaire de Tours
2016
Metabolism and Renal Physiology
2015
We propose to improve the prognostic assessment after radical prostatectomy (RP) by dividing high-risk prostate cancer (hrPCa) (according d'Amico classification) into subgroups combining 1, 2 or 3 criteria of aggressiveness (cT2c-T3a, PSA >20 ng/ml, Gleason score (GS) > 7). Data from 4795 hrPCa patients who underwent RP in two French university hospitals 1991 2013 were analyzed. Subgroups formed determine whether an increasing number (1, 3) tumor was associated with poorer oncological...
<i>Introduction</i>: Cervical cancer is a new tissue formation due to excessive, abnormal, anarchic and autonomous cell proliferation that develops at the expense of uterine cervix. In sub-Saharan Africa, with more than 75,000 cases nearly 50,000 deaths per year; The Kolondièba health district regularly records suspected cervical cancer, 473 women screened 68 were positive including 3 in 2022. Finally area 2024, out 16 June 9, 2024; during 23rd...
Postmenopausal hormone replacement therapy (HRT) with estrogen plus progestogens is the first line to treat menopausal symptoms. The progestogen added reduce or eliminate excess risk of endometrial cancer due unopposed effect estrogen. Whereas progestin clearly opposes proliferative and deleterious long-term actions on endometrium, interference other action remains unclear. We previously reported that chronic subcutaneous 17α-estradiol (E2) in mice decreases platelet responsiveness, prolongs...
To establish an external validation of the updated nomogram from Briganti et al., which provides estimates probability specimen-confined disease using variables age, prostate-specific antigen (PSA), clinical stage and biopsy Gleason score in preoperatively defined high-risk prostate cancer (PCa).The study included 523 patients with PCa, as by d'Amico classification, undergoing radical prostatectomy (RP) bilateral lymph node dissection one two academic centres between 1990 2013....
Transplantation from living donor nephrectomy (LDN) is the best treatment for end-stage renal disease but observed decrease in function a major concern. The aim of this study was to externally validate predictive model estimate 1-y postdonation estimated glomerular filtration rate (eGFR) and risk chronic kidney (CKD) donors.All LDN performed at Necker Hospital January 2006 May 2018 were retrospectively included. Observed eGFR (using CKD-EPI formula) post compared with predicted calculated...
Abstract The main objective of this preliminary study was to evaluate the feasibility and safety 3‐D laparoscopic living donor left nephrectomy (LDLN). secondary compare intraoperative postoperative outcomes between 2‐D LDLN. All patients who underwent a LDLN from January 2015 April 2018 in university center were included. surgeries performed by three experienced surgeons. Seventy included following: 16 (3‐D group), 57 (2‐D group). Operative time warm ischemia (WIT) significantly lower group...
You have accessJournal of UrologyKidney Cancer: Surgical Therapy II1 Apr 2015MP57-09 COMPARISON OF THE OPEN AND ROBOTIC APPROACH IN PARTIAL NEPHRECTOMY FOR HIGHLY COMPLEX TUMORS (RENAL NEPHROMETRY SCORE ≥ 10) Benoit Peyronnet, Tarek Fardoun, Thibaut Benoit, Mathieu Roumiguie, Gregory Verhoest, Jean-Baptiste Beauval, Michel Soulie, Nicolas Doumerc, and Karim Bensalah PeyronnetBenoit Peyronnet More articles by this author , FardounTarek Fardoun BenoitThibaut RoumiguieMathieu Roumiguie...
You have accessJournal of UrologyTransplantation & Vascular Surgery: Renal Transplantation Surgery I1 Apr 2016MP29-13 LIVING DONOR NEPHRECTOMY: A MULTICENTRIC COMPARATIVE STUDY BETWEEN STANDARD LAPAROSCOPIC AND ROBOT-ASSISTED NEPHRECTOMY. Benjamin Pradere, Benoit Peyronnet, Thibaut Benoit, Alexandre May, Frederico Salusto, Michel Soulié, Pascal Rischmann, nicolas Doumerc, Xavier Gamé, and Franck Bruyère PradereBenjamin Pradere More articles by this author , PeyronnetBenoit Peyronnet...
You have accessJournal of UrologyKidney Cancer: Localized: Surgical Therapy III (MP42)1 Apr 2019MP42-10 LONG TERM TRIFECTA OUTCOMES OF PARTIAL NEPHRECTOMY VERSUS PERCUTANEOUS ABLATION IN CT1A RENAL MASSES Bertrand Covin*, Thibaut Benoit, Marie Charlotte Delchier, Séverine Lagarde, Mathieu Roumiguié, Nicolas Doumerc, Matthieu Thoulouzan, Eric Huyghe, Xavier Gamé, Michel Soulié, and Jean Baptiste Beauval Covin*Bertrand Covin* More articles by this author , BenoitThibaut Benoit DelchierMarie...